Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.69 is 59% above its 5-year average of -1.67, near the high end of its 5-year range (-2.11–-0.69).
65.24% above its 12-month average of -1.98.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.69
EARNINGS PER SHARE (EPS) AVG TTM
-1.98
EARNINGS PER SHARE (EPS) AVG 3Y
-1.79
EARNINGS PER SHARE (EPS) AVG 5Y
-1.67
EARNINGS PER SHARE (EPS) AVG 10Y
-1.11
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+65.24%
CURRENT VS 3Y AVG
+61.45%
CURRENT VS 5Y AVG
+58.81%
CURRENT VS 10Y AVG
+37.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
INmune Bio, Inc.
Market Cap
$51.28M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$51.72M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.51
3Y Avg
-0.97
5Y Avg
-1.13
Market Cap
$51.51M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$50.95M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$48.03M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$53.13M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$53.01M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$52.99M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $51.28M | -0.69 | -1.98 | -1.79 | -1.67 |
| Microbot Medical Inc. (MBOT)vs › | $51.72M | -0.26 | -0.51 | -0.97 | -1.13 |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | -1.20 | -0.91 | -0.56 | -0.48 |
| biote Corp. (BTMD)vs › | $51.61M | 0.12 | 0.48 | 0.24 | 1.52 |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -0.67 | -1.36 | -1.71 | -1.31 |
| Celularity Inc. (CELU)vs › | $48.03M | -2.83 | -3.12 | -4.06 | -22.86 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.13M | -8.95 | -8.42 | -12.89 | -25.33 |
| ImageneBio Inc (IMA)vs › | $53.01M | -5.21 | -25.08 | -23.14 | -19.79 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.99M | N/A | -7.29 | -67.66 | -178.24 |
| Clene Inc. (CLNN)vs › | $49.00M | -3.55 | -4.16 | -5.92 | -5.28 |
Trailing EPS (TTM)
$-0.69
Forward EPS (Est.)
$-0.55
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.86 |
| 2024-12-31 | -2.11 |
| 2023-12-31 | -1.67 |
| 2022-12-31 | -1.52 |
| 2021-12-31 | -1.88 |
| 2020-12-31 | -1.01 |
| 2019-12-31 | -0.89 |
| 2018-12-31 | -1.11 |
| 2017-12-31 | -0.07 |
| 2016-12-31 | -0.05 |
| 2015-12-31 | -0.01 |
